The technical picture worsened for Eli Lilly stock in December as it completed a pattern known as a “Death Cross”. This ...

The government is expected to pay lower prices for Ozempic and Wegovy starting in 2027. The Trump administration will decide ...

Eli Lilly CEO said he believed the company could find “significant common cause” with the Trump administration, even if there ...

A letter from several Democratic Senators urged Trump to use his deal-making skills to “flat out reject any request to end ...

Just how much Medicare price negotiations will negatively impact Novo Nordisk, though, depends on what the final negotiated ...

The Biden administration said Medicare will negotiate discounts with drug companies on 15 drugs prescribed to treat cancer, ...

As the next round of Medicare drug pricing negotiations get underway, experts predict President Trump may seek to weaken the program.

In a live taping of "The Readout LOUD" at #JPM25, Eli Lilly CEO Dave Ricks talks Trump, Medicare's drug price negotiation, ...

Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will ...

Eli Lilly's diverse portfolio shows broad growth, with significant contributions from oncology and other therapeutic areas.

Unfortunately for the company, however, the early glimpse at its fourth-quarter performance doesn’t seem to be going over ...

Allurion catapulted nearly 200% early Friday after the company said it plans to test its weight-loss technology with an ...